Filing a 510(k), De Novo, or PMA without a verified strategy leads to costly Refusal to Accept (RTA) holds. This diagnostic evaluates your technical and quality system maturity against 2026 FDA standards.
Question 1 of 5
What is your primary product classification?
Does the device utilize AI, Machine Learning, or SaMD?
Is your QMS currently aligned with 2026 QMSR standards?
Have you completed your Design History File (DHF)?
